(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENEXINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GENEXINE

ST13

US500000079164375

Class

42

Filing

79164375

Registration

4806220

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

03/21/2025

Trademark type

Word

Nice classes

42

Filing date

12/15/2014

Registration date

09/08/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/20/2025

Last transaction

03/21/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

KR

Examiner

LEASER, ANDREW

Current location

Historical data usage

Holders and representatives

Holders

Genexine, Inc.
Genexine, Inc.
GENEXINE Co., Ltd.

Representatives

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development of vaccines and medicines; crude medicines research; research on adult diseases; bacteriological research; research on cancer; pharmaceutical products development; pharmaceutical products research; pharmaceutical products evaluation; consultancy pertaining to pharmacology; medical product testing; research for medical products; medical research; clinical trials; research and development of DNA chips; structural and functional analysis of genomes; biotechnology research; advisory services relating to biotechnology; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; testing/inspection or research on pharmaceuticals/cosmetics or food

Publications

History of USPTO decisions and trademark events.

26 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

03/20/2025

71AG

REGISTERED-SEC.71 ACCEPTED

03/20/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/17/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/07/2025

RNWL

INTERNATIONAL REGISTRATION RENEWED

12/19/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

11/28/2024

ES71

TEAS SECTION 71 RECEIVED

10/25/2024

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

09/08/2024

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

02/03/2021

71AG

REGISTERED-SEC.71 ACCEPTED

02/03/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/01/2021

ES71

TEAS SECTION 71 RECEIVED

11/30/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/28/2020

GPNX

NOTIFICATION PROCESSED BY IB

12/04/2015

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/16/2015

FIMP

FINAL DISPOSITION PROCESSED

11/16/2015

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

10/08/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

09/08/2015

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

06/26/2015

PUBO

PUBLISHED FOR OPPOSITION

06/23/2015

NPUB

NOTICE OF PUBLICATION

06/03/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/14/2015

MAFR

APPLICATION FILING RECEIPT MAILED

05/13/2015

DOCK

ASSIGNED TO EXAMINER

05/09/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/09/2015

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/07/2015

Continuous trademark protection

Get notified about every new filing that threatens GENEXINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.